Lowered Cancer Risk With ACE Inhibitors/ARBs: A Population-Based Cohort Study

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals

(2016)   JOURNAL OF HYPERTENSION

Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database

(2012) K. Bhaskaran et al.   BMJ-British Medical Journal

Meta-Analysis of Randomized Controlled Trials on Effect of Angiotensin-Converting Enzyme Inhibitors on Cancer Risk

(2011) Ilke Sipahi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension

(2011) Chin-Chou Huang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Candesartan-Based Therapy and Risk of Cancer in Patients With Systemic Hypertension (Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Substudy)

(2011) Ryo Sugiura et al.   AMERICAN JOURNAL OF CARDIOLOGY

Treatment of Kidney Transplant Recipients With ACEi/ARB and Risk of Respiratory Tract Cancer: A Collaborative Transplant Study Report

(2011) G. Opelz et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma

(2011) N Tanaka et al.   BRITISH JOURNAL OF CANCER

Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies

(2011) C. Yoon et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review

(2011) Úna C. Mc Menamin et al.   CANCER CAUSES & CONTROL

Use of Angiotensin Receptor Blockers and the Risk of Cancer

(2011) Björn Pasternak et al.   CIRCULATION

Significantly Increased Risk of Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis

(2011) Hiroshi Noto et al.   Endocrine Practice

Antihypertensive Drugs and the Risk of Prostate Cancer

(2011) Juan Morote et al.   EUROPEAN UROLOGY

Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study

(2011) Chia-Hsuin Chang et al.   JOURNAL OF CLINICAL ONCOLOGY

Preventable Exposures Associated With Human Cancers

(2011) V. J. Cogliano et al.   JNCI-Journal of the National Cancer Institute

Guidelines for good database selection and use in pharmacoepidemiology research

(2011) Gillian C. Hall et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Angiotensin II Receptor Blockers and Risk of Cancer: Cause for Concern?

(2010) Frederic Rahbari-Oskoui   AMERICAN JOURNAL OF KIDNEY DISEASES

Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine

(2010) Y Nakai et al.   BRITISH JOURNAL OF CANCER

Cancer Trends in Taiwan

(2010) C.-J. Chiang et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Effect of RAAS Inhibition on the Incidence of Cancer and Cancer Mortality in Patients with Glomerulonephritis

(2010) Ho Jun Chin et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

(2010) Ilke Sipahi et al.   LANCET ONCOLOGY

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

(2010) Sripal Bangalore et al.   LANCET ONCOLOGY

A review of human carcinogens—Part F: Chemical agents and related occupations

(2009) Robert Baan et al.   LANCET ONCOLOGY

Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor

(2009) D. R. Soto-Pantoja et al.   MOLECULAR CANCER THERAPEUTICS

Prevalence, trend, and sociodemographic association of five modifiable lifestyle risk factors for cancer in Alberta and Canada

(2008) Feng Xiao Li et al.   CANCER CAUSES & CONTROL